U.S. Health Secretary Robert F. Kennedy Jr. advocates for expanded access to experimental and unregulated stem cell treatments, despite known risks and potential for harm, criticizing the FDA's regulation of alternative medicine.
Experimental therapies for cancer should be assessed based on evidence, with FDA-approved drugs recommended in cancer guidelines being the most reliable options. Most experimental cancer treatments fail, and early-stage treatments are not helpful for those with cancer now. Late-stage clinical trials offer the best chance for next-generation treatments before approval, and cancer patients should ask their oncologists about promising trials. Understanding cancer and its treatment can ease fears, and an AI cancer counselor could be a valuable resource for patients to access evidence-based information.